Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

From Quasicrystals to Crystals with Interpenetrating Icosahedra in Ca-Au-Al: In Situ Variable-Temperature Transformation.

Pham J, Meng F, Lynn MJ, Ma T, Kreyssig A, Kramer MJ, Goldman AI, Miller GJ.

J Am Chem Soc. 2018 Jan 31;140(4):1337-1347. doi: 10.1021/jacs.7b10358. Epub 2018 Jan 22.

PMID:
29284266
2.

Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.

Turan TN, Al Kasab S, Nizam A, Lynn MJ, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.

PMID:
29169967
3.

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Cotsonis GA, Lane BF, Montgomery J, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2017 Jun;48(6):1501-1506. doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.

PMID:
28455321
4.

Myopic Shift 5 Years after Intraocular Lens Implantation in the Infant Aphakia Treatment Study.

Weakley DR Jr, Lynn MJ, Dubois L, Cotsonis G, Wilson ME, Buckley EG, Plager DA, Lambert SR; Infant Aphakia Treatment Study Group.

Ophthalmology. 2017 Jun;124(6):822-827. doi: 10.1016/j.ophtha.2016.12.040. Epub 2017 Feb 16.

5.

Relationship between risk factor control and vascular events in the SAMMPRIS trial.

Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane B, Montgomery J, Chimowitz MI.

Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.

6.

Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?

Turan TN, Smock A, Cotsonis G, Bachman D, Al Kasab S, Lynn MJ, Nizham A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Cerebrovasc Dis. 2017;43(1-2):31-35. doi: 10.1159/000450964. Epub 2016 Nov 5.

7.

Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years.

Bothun ED, Lynn MJ, Christiansen SP, Kruger SJ, Vanderveen DK, Neely DE, Lambert SR; Infant Aphakic Treatment Study.

J AAPOS. 2016 Dec;20(6):501-505. doi: 10.1016/j.jaapos.2016.09.014. Epub 2016 Nov 2.

8.

Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.

Al Kasab S, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):108-115. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.038. Epub 2016 Oct 17.

PMID:
27765556
9.

Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS).

Bothun ED, Lynn MJ, Christiansen SP, Neely DE, Vanderveen DK, Kruger SJ, Lambert SR; Infant Aphakia Treatment Study.

J AAPOS. 2016 Feb;20(1):49-53. doi: 10.1016/j.jaapos.2015.11.002.

10.

A Comparison of Sequential Glaucoma Drainage Device Implantation Versus Cyclophotocoagulation Following Failure of a Primary Drainage Device.

Levinson JD, Giangiacomo AL, Beck AD, Pruett PB, Superak HM, Lynn MJ, Costarides AP.

J Glaucoma. 2017 Apr;26(4):311-314. doi: 10.1097/IJG.0000000000000370.

11.

Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.

Waters MF, Hoh BL, Lynn MJ, Kwon HM, Turan TN, Derdeyn CP, Fiorella D, Khanna A, Sheehan TO, Lane BF, Janis S, Montgomery J, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial Investigators.

JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

12.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators.

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

13.

Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.

Chiu D, Klucznik RP, Turan TN, Lynn MJ, McCane CD, Katz LB, Nizam A, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis S, Chimowitz MI.

Neurology. 2015 Dec 15;85(24):2090-7. doi: 10.1212/WNL.0000000000002191. Epub 2015 Nov 11.

14.

Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?

Lutsep HL, Lynn MJ, Cotsonis GA, Derdeyn CP, Turan TN, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Nov;46(11):3282-4. doi: 10.1161/STROKEAHA.115.009846. Epub 2015 Sep 17. Erratum in: Stroke. 2015 Nov;46(11):e248.

15.

Corneal Changes in Children after Unilateral Cataract Surgery in the Infant Aphakia Treatment Study.

Morrison DG, Lynn MJ, Freedman SF, Orge FH, Lambert SR; Infant Aphakia Treatment Study Group.

Ophthalmology. 2015 Nov;122(11):2186-92. doi: 10.1016/j.ophtha.2015.07.011. Epub 2015 Aug 11.

16.

Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?

Chaturvedi S, Turan TN, Lynn MJ, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2015 Sep;46(9):2562-7. doi: 10.1161/STROKEAHA.115.009656. Epub 2015 Aug 6.

17.

Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography.

Ryan ME, Rajalakshmi R, Prathiba V, Anjana RM, Ranjani H, Narayan KM, Olsen TW, Mohan V, Ward LA, Lynn MJ, Hendrick AM.

Ophthalmology. 2015 Oct;122(10):2038-43. doi: 10.1016/j.ophtha.2015.06.011. Epub 2015 Jul 16.

18.

Glaucoma drainage devices: risk of exposure and infection.

Levinson JD, Giangiacomo AL, Beck AD, Pruett PB, Superak HM, Lynn MJ, Costarides AP.

Am J Ophthalmol. 2015 Sep;160(3):516-521.e2. doi: 10.1016/j.ajo.2015.05.025. Epub 2015 May 30.

19.

Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study.

Freedman SF, Lynn MJ, Beck AD, Bothun ED, Örge FH, Lambert SR; Infant Aphakia Treatment Study Group.

JAMA Ophthalmol. 2015 Aug;133(8):907-14. doi: 10.1001/jamaophthalmol.2015.1329.

20.

The Infant Aphakia Treatment Study: further on intra- and postoperative complications in the intraocular lens group.

Lambert SR, Plager DA, Buckley EG, Wilson ME, DuBois L, Drews-Botsch CD, Hartmann EE, Lynn MJ; Infant Aphakia Treatment Study Group.

J AAPOS. 2015 Apr;19(2):101-3. doi: 10.1016/j.jaapos.2015.01.012. No abstract available.

21.

Comparison of central and peripheral corneal thickness measurements with scanning-slit, Scheimpflug and Fourier-domain ocular coherence tomography.

Randleman JB, Lynn MJ, Perez-Straziota CE, Weissman HM, Kim SW.

Br J Ophthalmol. 2015 Sep;99(9):1176-81. doi: 10.1136/bjophthalmol-2014-306340. Epub 2015 Mar 30.

PMID:
25824260
22.

Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.

Lutsep HL, Barnwell SL, Larsen DT, Lynn MJ, Hong M, Turan TN, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Mar;46(3):775-9. doi: 10.1161/STROKEAHA.114.007752. Epub 2015 Jan 15.

23.

Comparison of objective and subjective refractive surgery screening parameters between regular and high-resolution Scheimpflug imaging devices.

Randleman JB, Akhtar J, Lynn MJ, Ambrósio R Jr, Dupps WJ Jr, Krueger RR, Klyce SD.

J Cataract Refract Surg. 2015 Feb;41(2):286-94. doi: 10.1016/j.jcrs.2014.06.026. Epub 2014 Dec 20.

24.

Histopathologic grading of anaplasia in retinoblastoma.

Mendoza PR, Specht CS, Hubbard GB, Wells JR, Lynn MJ, Zhang Q, Kong J, Grossniklaus HE.

Am J Ophthalmol. 2015 Apr;159(4):764-76. doi: 10.1016/j.ajo.2014.12.014. Epub 2014 Dec 19.

25.

Baseline characteristics of the infant aphakia treatment study population: predicting recognition acuity at 4.5 years of age.

Hartmann EE, Lynn MJ, Lambert SR; Infant Aphakia Treatment Study Group.

Invest Ophthalmol Vis Sci. 2014 Dec 11;56(1):388-95. doi: 10.1167/iovs.14-15464.

26.

Reply: To PMID 25077835.

Plager DA, Lynn MJ, Lambert SR, Buckley EG, Wilson ME; Infant Aphakia Treatment Study Group.

Am J Ophthalmol. 2014 Dec;158(6):1361-2. doi: 10.1016/j.ajo.2014.09.019. Epub 2014 Nov 18. No abstract available.

27.

ANALYSIS OF DEPENDENTLY CENSORED DATA BASED ON QUANTILE REGRESSION.

Ji S, Peng L, Li R, Lynn MJ.

Stat Sin. 2014;24(3):1411-1432.

28.

The effects of surgical factors on postoperative astigmatism in patients enrolled in the Infant Aphakia Treatment Study (IATS).

Wall PB, Lee JA, Lynn MJ, Lambert SR, Traboulsi EI; Infant Aphakia Treatment Study Group.

J AAPOS. 2014 Oct;18(5):441-5. doi: 10.1016/j.jaapos.2014.06.016. Epub 2014 Sep 27.

29.

Stereopsis results at 4.5 years of age in the infant aphakia treatment study.

Hartmann EE, Stout AU, Lynn MJ, Yen KG, Kruger SJ, Lambert SR; Infant Aphakia Treatment Study Group; Infant Aphakia Treatment Study Group.

Am J Ophthalmol. 2015 Jan;159(1):64-70.e1-2. doi: 10.1016/j.ajo.2014.09.028. Epub 2014 Sep 28.

30.

In reply.

Lambert SR, Lynn MJ, Hartmann EE; Infant Aphakia Treatment Study Group.

JAMA Ophthalmol. 2014 Dec;132(12):1492-3. doi: 10.1001/jamaophthalmol.2014.3542. No abstract available.

31.

Nystagmus and related fixation instabilities following extraction of unilateral infantile cataract in the Infant Aphakia Treatment Study (IATS).

Felius J, Busettini C, Lynn MJ, Hartmann EE, Lambert SR; Infant Aphakia Treatment Study Group.

Invest Ophthalmol Vis Sci. 2014 Aug 5;55(8):5332-7. doi: 10.1167/iovs.14-14710.

32.

Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study.

Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR; Infant Aphakia Treatment Study Group.

Am J Ophthalmol. 2014 Nov;158(5):892-8. doi: 10.1016/j.ajo.2014.07.031. Epub 2014 Jul 29.

33.

Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.

López-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, Cotsonis GA, Lynn MJ, Rumboldt Z, Chimowitz MI.

Cerebrovasc Dis. 2014;37(6):417-22. doi: 10.1159/000362922. Epub 2014 Jul 4.

34.

The Handy Eye Check: a mobile medical application to test visual acuity in children.

Toner KN, Lynn MJ, Candy TR, Hutchinson AK.

J AAPOS. 2014 Jun;18(3):258-60. doi: 10.1016/j.jaapos.2014.01.011.

PMID:
24924280
35.

The role of preoperative biometry in selecting initial contact lens power in the Infant Aphakia Treatment Study.

Trivedi RH, Lambert SR, Lynn MJ, Wilson ME; Infant Aphakia Treatment Study Group.

J AAPOS. 2014 Jun;18(3):251-4. doi: 10.1016/j.jaapos.2014.01.012.

36.

Author reply: To PMID 23419803.

Bothun ED, Lynn MJ, Lambert SR.

Ophthalmology. 2014 Oct;121(10):e53. doi: 10.1016/j.ophtha.2014.05.011. Epub 2014 Jun 6. No abstract available.

37.

Reply: To PMID 24011524.

VanderVeen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR.

Am J Ophthalmol. 2014 Jun;157(6):1332-3. doi: 10.1016/j.ajo.2014.02.053. No abstract available.

38.

Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years.

Infant Aphakia Treatment Study Group, Lambert SR, Lynn MJ, Hartmann EE, DuBois L, Drews-Botsch C, Freedman SF, Plager DA, Buckley EG, Wilson ME.

JAMA Ophthalmol. 2014 Jun;132(6):676-82.

39.

Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis.

Liebeskind DS, Kosinski AS, Lynn MJ, Scalzo F, Fong AK, Fariborz P, Chimowitz MI, Feldmann E.

J Neuroimaging. 2015 Jan-Feb;25(1):87-91. doi: 10.1111/jon.12101. Epub 2014 Mar 5.

40.

Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.

Turan TN, Cotsonis G, Lynn MJ, Wooley RH, Swanson S, Williams JE, Stern BJ, Derdeyn CP, Fiorella D, Chimowitz MI.

Cerebrovasc Dis. 2014;37(3):203-11. doi: 10.1159/000358120. Epub 2014 Feb 19.

41.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

42.

Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study.

Vanderveen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR; Infant Aphakia Treatment Study Group.

Am J Ophthalmol. 2013 Dec;156(6):1252-1260.e2. doi: 10.1016/j.ajo.2013.07.014. Epub 2013 Sep 4.

43.

Reply: To PMID 23639132.

Lambert SR, Superak HM, Lynn MJ, Beck AD.

Am J Ophthalmol. 2013 Sep;156(3):629. doi: 10.1016/j.ajo.2013.06.002. No abstract available.

44.

Intracranial stenting: SAMMPRIS.

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Lane BF, Janis LS, Chimowitz MI.

Stroke. 2013 Jun;44(6 Suppl 1):S41-4. doi: 10.1161/STROKEAHA.111.000370. Review. No abstract available.

45.

Long-term risk of glaucoma after congenital cataract surgery.

Lambert SR, Purohit A, Superak HM, Lynn MJ, Beck AD.

Am J Ophthalmol. 2013 Aug;156(2):355-361.e2. doi: 10.1016/j.ajo.2013.03.013. Epub 2013 Apr 30.

46.

One-year strabismus outcomes in the Infant Aphakia Treatment Study.

Bothun ED, Cleveland J, Lynn MJ, Christiansen SP, Vanderveen DK, Neely DE, Kruger SJ, Lambert SR; Infant Aphakic Treatment Study.

Ophthalmology. 2013 Jun;120(6):1227-31. doi: 10.1016/j.ophtha.2012.11.039. Epub 2013 Feb 16.

47.

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Derdeyn CP, Fiorella D, Lynn MJ, Rumboldt Z, Cloft HJ, Gibson D, Turan TN, Lane BF, Janis LS, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Neurosurgery. 2013 May;72(5):777-95; discussion 795. doi: 10.1227/NEU.0b013e318286fdc8.

48.

Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.

Chimowitz MI, Fiorella D, Derdeyn CP, Turan TN, Lane BF, Janis S, Lynn MJ.

Stroke. 2012 Oct;43(10):2806-9. No abstract available.

49.

Axial elongation following cataract surgery during the first year of life in the infant Aphakia Treatment Study.

Lambert SR, Lynn MJ, DuBois LG, Cotsonis GA, Hartmann EE, Wilson ME; Infant Aphakia Treatment Study Groups.

Invest Ophthalmol Vis Sci. 2012 Nov 7;53(12):7539-45. doi: 10.1167/iovs.12-10285.

50.

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Turan TN, Lynn MJ, Nizam A, Lane B, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Benavente O, White CL, Brown WV, Caskey MF, Steiner MR, Vilardo N, Stufflebean A, Derdeyn CP, Fiorella D, Janis S, Chimowitz MI; SAMMPRIS Investigators.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. No abstract available.

Supplemental Content

Support Center